Gilbert Thompson
#102,354
Most Influential Person Now
Physician, born 1932
Gilbert Thompson 's AcademicInfluence.com Rankings
Gilbert Thompson philosophy Degrees
Philosophy
#6435
World Rank
#9470
Historical Rank
Ontology
#58
World Rank
#68
Historical Rank
Logic
#3601
World Rank
#4789
Historical Rank
Download Badge
Philosophy
Why Is Gilbert Thompson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Gilbert R. Thompson is a British physician and researcher in lipidology. Thompson studied at St Thomas' Hospital Medical School, graduating in 1956. After National Service, he was at the Royal Postgraduate Medical School Hospital from 1963 to 1998, but including time at Massachusetts General Hospital, the Methodist Hospital, Houston and the Royal Victoria Hospital, Montreal, as a researcher.
Gilbert Thompson 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. (1990) (595)
- PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA (1975) (373)
- Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. (1981) (285)
- Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. (1986) (271)
- Recommendations for the use of LDL apheresis. (2008) (268)
- Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk (2006) (262)
- Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. (1983) (242)
- Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis (1995) (238)
- Triglyceride‐Lowering Effect of Marine Polyunsaturates in Patients with Hypertriglyceridemia (1985) (205)
- Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange. (1985) (203)
- Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil. (1986) (180)
- Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. (1966) (179)
- Role of cholesterol in regulating apolipoprotein B secretion by the liver. (1996) (175)
- Simultaneous measurement of apolipoprotein B turnover in very-low-and low-density lipoproteins in familial hypercholesterolaemia. (1977) (161)
- Assessment of long-term plasma exchange for familial hypercholesterolaemia. (1980) (151)
- The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients (1994) (148)
- History and development of plant sterol and stanol esters for cholesterol-lowering purposes. (2005) (145)
- Gastrointestinal structure and function in germ-free or gnotobiotic animals. (1971) (141)
- Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. (1987) (132)
- Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. (1993) (128)
- Efficacy criteria and cholesterol targets for LDL apheresis. (2010) (125)
- Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia. (1997) (122)
- High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. (1988) (111)
- Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe (2010) (107)
- A roentgenologically distinctive arthropathy in some patients with the pseudogout syndrome. (1970) (104)
- Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM (1995) (101)
- Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia (2004) (98)
- Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia (1998) (96)
- Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease. (1989) (95)
- Current management of severe homozygous hypercholesterolaemias (2004) (94)
- Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia. (1996) (92)
- Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin. (1997) (88)
- Cadiovascular complications of homozygous familial hypercholesterolaemia. (1980) (84)
- Comparison of efficacy of plant stanol ester and sterol ester: short-term and longer-term studies. (2005) (83)
- Action of neomycin on the intraluminal phase of lipid absorption. (1971) (83)
- The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia. (1982) (79)
- Vitamin-D absorption after partial gastrectomy. (1966) (77)
- Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin (1994) (74)
- Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol (2018) (71)
- HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. (2016) (70)
- Circulating human C-reactive protein binds very low density lipoproteins. (1984) (70)
- Characterization of deletions in the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom. (1992) (69)
- Determinants of Variable Response to Statin Treatment in Patients With Refractory Familial Hypercholesterolemia (2001) (69)
- Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease. (1995) (65)
- Effect of phenobarbitone treatment on vitamin D metabolism in mammals. (1974) (65)
- The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease. (2013) (64)
- Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects. (1995) (63)
- PLASMA EXCHANGE FOR HYPERCHOLESTEROLAEMIA (1981) (61)
- Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy. (1994) (60)
- Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. (2004) (58)
- Genotypic and phenotypic variation in familial hypercholesterolemia. (1989) (57)
- Why some patients respond poorly to statins and how this might be remedied. (2002) (56)
- Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia. (1986) (54)
- The Extracranial Carotid Artery in Familial Hypercholesterolemia: Relationship of Intimal-Medial Thickness and Plaque Morphology with Plasma Lipids and Coronary Heart Disease (1996) (52)
- Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances (2014) (51)
- Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. (1991) (51)
- Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome (2003) (50)
- Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk. (1984) (50)
- Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom. (1996) (50)
- Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. (2003) (50)
- Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia. (1992) (49)
- Current Role of Lipoprotein Apheresis (2019) (48)
- Effect of mixed micellar lipid on the absorption of cholesterol and vitamin D3 into lymph. (1969) (48)
- Detection of vitamin-d deficiency after partial gastrectomy. (1966) (47)
- SUPERIORITY OF PARTIAL ILEAL BYPASS OVER CHOLESTYRAMINE IN REDUCING CHOLESTEROL IN FAMILIAL HYPERCHOLESTEROLAEMIA (1981) (46)
- Diagnosis and Treatment of Essential Fatty Acid Deficiency in Man (1974) (45)
- Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration. (1989) (44)
- Difference in saturable binding of low density lipoprotein to liver membranes from normocholesterolemic subjects and patients with heterozygous familial hypercholesterolemia. (1982) (44)
- What targets should lipid-modulating therapy achieve to optimise the prevention of coronary heart disease? (1997) (42)
- Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis. (1978) (42)
- Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. (1997) (41)
- Hyperlipidaemia and premature coronary artery disease associated with sex-change in a female. (1985) (41)
- Reduction of blood viscosity following plasma exchange. (1979) (39)
- Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. (2003) (38)
- Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes. (2015) (38)
- Non-stedy-state studies of low-density-liproprotein turnover in familial hypercholesterolaemia. (1977) (37)
- The Effect of Cholesterol Reduction with Fluvastatin on Aortic Compliance, Coronary Calcification and Carotid Intimal-Medial Thickness: A Pilot Study (1998) (37)
- Fatty acid composition of plasma lipoproteins in control subjects and in patients with malabsorption (1973) (36)
- Management of dyslipidaemia (2004) (36)
- Additive effects of plant sterol and stanol esters to statin therapy. (2005) (34)
- Aortic stenosis in homozygous familial hypercholesterolaemia. (1996) (34)
- The Bowie and Dick autoclave tape test. (1963) (33)
- Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia. (1985) (32)
- Cross sectional echocardiographic assessment of the aortic root and coronary ostial stenosis in familial hypercholesterolaemia. (1983) (32)
- Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia. (1996) (31)
- Effect of cholestyramine on the absorption of vitamin D3 and calcium (1969) (31)
- Clinical lipidology at the end of the millennium. (1999) (31)
- Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction. (1996) (31)
- Subclinical vitamin-D deficiency following gastric surgery. Histological evidence in bone. (1968) (31)
- Metabolism of apolipoprotein B-containing lipoproteins in familial hypercholesterolaemia: effects of plasma exchange. (1979) (31)
- Behavior of human apolipoprotein A-I: phospholipid and apoHDL:phospholipid complexes in vitro and after injection into rabbits. (1988) (31)
- Serum lipids and high density lipoprotein cholesterol in peripheral vascular disease (1980) (30)
- Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia. (1981) (29)
- Low density lipoprotein turnover in familial hypercholesterolaemia after plasma exchange (1976) (27)
- Solid phase radioimmunoassay of apolipoprotein B (apo B) in normal human plasma. (1976) (26)
- HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin. (1990) (26)
- Lipids and cardiovascular disease. (1990) (25)
- Renal failure in familial lecithin: cholesterol acyltransferase deficiency. (1982) (25)
- Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart. (1991) (24)
- Absorption of fat-soluble vitamins and sterols (1971) (24)
- COLLAGEN CONTENT OF ATHEROSCLEROTIC ARTERIES IS HIGHER IN SMOKERS THAN IN NON-SMOKERS (1983) (24)
- Novel lipid-regulating drugs (2000) (24)
- Intra-amniotic methotrexate versus CO2 laser laparoscopic salpingotomy in the management of tubal ectopic pregnancy--a prospective randomized trial. (1994) (23)
- A Hepatic Ectopic Pregnancy Treated with Direct Methotrexate Injection (1995) (23)
- Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease. (1984) (23)
- Systemic candidiasis (moniliasis) complicating treatment of bacterial endocarditis, with review of literature and report of apparent cure of one case with parenteral mycostatin. (1958) (22)
- Plasma Exchange and Low Density Lipoprotein Apheresis in Watanabe Heritable Hyperlipidemic Rabbits (1987) (22)
- Normal adrenocortical response to adrenocorticotrophic hormone in patients with homozygous familial hypercholesterolaemia. (1983) (22)
- Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100. (1991) (20)
- Kinetics of LDL subfractions. (1987) (20)
- Angiographic evidence for the role of triglyceride-rich lipoproteins in progression of coronary artery disease. (1998) (20)
- Angiographic trials of lipid-lowering therapy: end of an era? (1995) (19)
- Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017. (2019) (19)
- Progression and regression of coronary artery disease (1992) (19)
- Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man. (1997) (19)
- Lipid related consequences of intestinal malabsorption. (1989) (18)
- Managing homozygous familial hypercholesterolaemia from cradle to grave. (2015) (17)
- Binding and degradation of heavy and light subfractions of low density lipoprotein by cultured fibroblasts and macrophages. (1986) (17)
- PLASMA MEVALONATE RESPONSE IN LOVASTATIN-RELATED MYOPATHY (1989) (17)
- Management of hyperlipidemia in the pediatric population (2004) (16)
- HMG-CoA reductase is not the site of the primary defect in phytosterolemia. (1998) (16)
- Lipoprotein apheresis for the treatment of familial hypercholesterolemia (2013) (16)
- Plasma Cholesterol Esterification in Patients with Secondary Hypocholesterolaemia (1973) (15)
- Effect of jogging on serum low density lipoprotein cholesterol. (1980) (15)
- Plasma lipid and lipoprotein abnormalities in patients with malabsorption. (1973) (15)
- Lipoprotein(a): the underestimated cardiovascular risk factor (2013) (14)
- Evidence that lowering serum lipids favourably influences coronary heart disease. (1987) (14)
- Ileal bypass in the treatment of hyperlipoproteinaemia. (1973) (14)
- Guidelines for the management of dyslipidaemia (2006) (13)
- History of the cholesterol controversy in Britain. (2008) (13)
- Electron-beam CT scanning for detection of coronary calcification and prediction of coronary heart disease. (1996) (13)
- Coronary Calcification and Predicted Risk of Coronary Heart Disease in Asymptomatic Men with Hypercholesterolaemia1 (2002) (12)
- Predicting coronary heart disease (1994) (12)
- The proving of the lipid hypothesis. (1999) (12)
- Primary hyperlipidaemia. (1990) (12)
- The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia. (1997) (12)
- Upregulation of cholesterol synthesis after acute reduction of low density lipoprotein by apheresis in normocholesterolaemic subjects: evidence for a threshold effect. (1997) (11)
- Lipid lowering in the young. (1996) (11)
- Screening relatives of patients with premature coronary heart disease (2002) (11)
- Regression of atherosclerosis. (1980) (11)
- The effect of phenobarbitone-induction on vitamin D metabolism. (1972) (11)
- Is good cholesterol always good? (2004) (10)
- Effect of phenobarbitone-induction on the excretion of vitamin D metabolites in bile. (1972) (10)
- Reappraisal of partial ileal bypass for the treatment of familial hypercholesterolemia. (1989) (10)
- Goals of statin therapy: three viewpoints. (2004) (10)
- Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100. (1992) (10)
- LDL apheresis. (2003) (9)
- Current management of hyperlipidaemia. (1989) (9)
- THE EFFECT OF CHLOROQUINE ON ANTIBODY PRODUCTION. (1964) (9)
- Laboratory facilities for investigating lipid disorders in the United Kingdom: results of the British Hyperlipidaemia Association survey. (1992) (9)
- Failure of experimental atherosclerosis to sensitize coronary arteries to spasm in hypercholesterolemic rabbits. (1985) (9)
- The mechanism of steatorrhea in induced hyperthyroidism in the rat. (1969) (9)
- SATURATION OF FAT AND CHOLECYSTOKININ RELEASE (1989) (9)
- Role of LDL apheresis in the management of hypercholesterolaemia. (1993) (8)
- Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans. (2018) (8)
- Measurement of the reflectivity of the intima-medial layer of the common carotid artery improves the discriminatory value of intima-medial thickness measurement as a predictor of risk of atherosclerotic disease. (2007) (8)
- Poor responders to statins : a potential target for stanol esters (1999) (8)
- Low-density-lipoprotein apheresis (1995) (7)
- Grand Rounds--Hammersmith Hospital: Hazards of running a marathon (1997) (7)
- DEFECTIVE ESSENTIAL-FATTY-ACID METABOLISM IN CYSTIC FIBROSIS (1975) (7)
- Vitamin D deficiency after gastrectomy. (1970) (7)
- The metabolism in vivo and in vitro of plasma low-density lipoprotein from a subject with inherited hypercholesterolaemia. (1976) (7)
- Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity? (1995) (7)
- Enhancement of cholesterol-lowering effect of atorvastatin by stanol ester cereal bars (2001) (7)
- Plant lipids that lower serum cholesterol. (1999) (6)
- New prospects for lipid-lowering drugs. (1998) (6)
- Efficacy of ezetimibe and future role in the management of refractory hyperlipidaemia in high-risk patients (2008) (6)
- Experience with plasma-exchange in homozygous familial hypercholesterolaemia. (1985) (6)
- Radical therapy of atherosclerosis by apheresis or liver transplantation (1994) (6)
- Essential fatty acid deficiency secondary to intestinal malabsorption. (1972) (6)
- PLASMA LIPIDS AND LIPOPROTEINS AFTER MODIFIED FAT DIET (1980) (6)
- Comparison of absorption of a polar and non-polar lipid from micellar solutions and emulsions. (1969) (5)
- Effects of intravenous vitamin D on bone and phosphate metabolism in osteomalacia (1969) (5)
- Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasis (2009) (5)
- Combined Medico-Surgical Strategy for Severe Familial Hypercholesterolaemia (1980) (5)
- Lipoprotein (a) and coronary heart disease in patients with familial hypercholesterolemia. (1990) (5)
- Direct correlation between in vivo cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidaemic subjects (1994) (5)
- Turnover of Light and Heavy Fractions of Human LDL in Normal and WHHL Rabbits (1986) (5)
- First priority is to decrease the severity of hyperchylomicronaemia (1997) (5)
- The scientific basis and future of lipoprotein apheresis (2021) (5)
- The effect of partial ileal bypass on receptor-mediated uptake and catabolism of low density lipoprotein in the rhesus monkey (1982) (4)
- Goals of statin therapy: Three viewpoints (2002) (4)
- Plasma post-heparin lipolytic activity in patients with malabsorption: effect of intravenous fat administration. (1974) (4)
- Lipids, fish and coronary heart disease (1986) (4)
- Inhibitory effect of neomycin on cholesterol absorption in germ-free pigs. (1970) (4)
- Effects of starvation and plasma exchange on lecithin: Cholesterol acyltransferase activity and cholesterol efflux in cholesterol-fed pigs (1984) (4)
- Plasma exchange and LDL apheresis. (1988) (4)
- Effects of Partial Ileal Bypass on Receptor-Mediated Low Density Lipoprotein Catabolism (1981) (4)
- Which lipid fraction is the target and how often should this be monitored? (2010) (4)
- Effect of Enprostil on Glucose and Lipid Metabolism in Type 2 Diabetes (1989) (4)
- Studies in the absorption and metabolism of vitamin D after gastric surgery. (1968) (4)
- Cholesterol flux in cholesterol ester-loaded macrophages in an in vitro perfusion system. (1991) (4)
- Increased Rate of Metabolism of Vitamin D 3 in Phenobarbitone-Induced Rats (1972) (4)
- Effect of hyperlipidaemia on pulmonary diffusing capacity for carbon monoxide. (1978) (4)
- Lipoprotein apheresis (2010) (4)
- Control of plasma HDL levels after plasmapheresis. (1986) (4)
- Dyslipidaemia in Clinical Practice (2001) (4)
- USE OF PLASMA-PROTEIN FUNCTION IN PLASMA EXCHANGE (1976) (4)
- Cholesterol lowering margarine is effective (1999) (4)
- Apolipoprotein AI Gene Polymorphisms: Frequency in Patients with Coronary Artery Disease and Healthy Controls and Association with Serum APO A-I and HDL-C Concentration (1989) (3)
- Cholesterol synthesis is increased in mixed hyperlipidaemia. (1998) (3)
- Accentuation of ethanol-induced fatty liver by phenobarbitone. (1977) (3)
- Steatorrhoea in hyperthyroidism. (1968) (3)
- Non-st eady-s t ate studies of lo w-densit y-lipro pro tein turnover in familial hypercholesterolaemia (1977) (3)
- The effects of intra-venous diazoxide, a non-diuretic thiazide, upon blood pressure, electrolyte, and uric acid excretion. (1966) (3)
- Evidence for Defect of Receptor-Mediated Low-Density Lipoprotein Catabolism in Familial Hypercholesterolaemia In Vivo (1980) (3)
- A cautionary tale of undetected hyperlipidaemia: implications for coronary artery bypass grafting. (1994) (3)
- Limitations of cholesterol lowering with PCSK9 inhibitors. (2017) (3)
- HIGH-DENSITY LIPOPROTEINS AND PERIPHERAL VASCULAR DISEASE (1979) (3)
- Effects of Ldl Apheresis on Cholesterol Biosynthesis (1994) (3)
- Changes in the fatty acid composition of plasma lipoproteins during administration of Intralipid to a patient with essential fatty acid deficiency. (1974) (3)
- Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study (2012) (3)
- Cardiovascular disease prevention and the rise in dementia. (2012) (3)
- FH through the retrospectoscope (2020) (2)
- Lipid‐lowering therapy in perspective (1988) (2)
- Uptake and cellular degradation of low-density lipoprotein. (1980) (2)
- Neomycin's Mode of Action (1972) (2)
- Towards a new era: is coronary artery disease reversible? (1990) (2)
- Frequency of citation and outcome of cholesterol lowering trials. (1992) (2)
- Genetic and environmental determinants of plasma lipoproteins relevant to coronary heart disease. (1987) (2)
- Early results of a cohort study of severe hyperlipidaemia (1989) (2)
- Facilities for the management of patients with lipid disorders in the United Kingdom: results of the British Hyperlipidaemia Association Survey. (1991) (2)
- Mechanism of o,p′-DDD-induced hypercholesterolaemia in patients with cushing's disease (1990) (2)
- Peptic ulcer following rectal steroids. (1963) (2)
- Interaction of neomycin with micellar fatty acid and cholesterol. (1969) (2)
- Abnormalities of Plasma Lipoprotein Transport (1999) (2)
- PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia: Useful But Seldom Sufficient. (2020) (2)
- 4.P.285 Inhibition of cholesterogenesis decreases hepatic secretion of apolipoprotein B-100 in normolipidaemic subjects (1997) (2)
- Effect ofcholestyramine on theabsorption of vitamin D3andcalcium (1969) (2)
- New approaches to dietary management of elevated cholesterol : proceedings of an international conference held in Dublin, Ireland, 28-30 January, 1999 (1999) (2)
- Cholesterol lowering and non-cardiac mortality (1991) (2)
- FH through the retrospectoscope. (2021) (2)
- PREVENTION OF CORONARY HEART DISEASE (1974) (2)
- Coronary calcification score and predicted risk of coronary heart disease (2000) (2)
- Diet and coronary heart disease. (1974) (2)
- Association between apolipoprotein (APO) AI & HDL-cholesterol concentrations & APO AI DNA polymorphisms (1987) (2)
- Lymphatic and portal venous transport of alpha-tocopherol and cholesterol. (1971) (2)
- hypercholesterolemia in the United Kingdom Characterization of deletions in the LDL receptor gene in patients with familial (2011) (2)
- The familial hypercholesterolemia regression study: a randomized comparison of therapeutic reduction of both low-density lipoprotein and lipoprotein(a) versus low-density lipoprotein alone. (1997) (2)
- Serum antinuclear factors associated with systemic lupus erythematosus. (1962) (1)
- Prevalence of Hyperlipidaemia in British Compared with North American Men (1987) (1)
- What should be done about asymptomatic hypercholesterolaemia? (1991) (1)
- Plasma lipoproteins and post-heparin lipolytic activity in patients with intestinal malabsorption. (1972) (1)
- Turnover and interconversion of LDL sub-fractions. (1987) (1)
- Studies in the absorption and metabolism of vitamin D. (1969) (1)
- New developments in pharmacotherapy. (2004) (1)
- International Conference on New Approaches to Dietary Management of Elevated Cholesterol, Dublin, 28th-30th January 1999: Foreword (1999) (1)
- Use of apheresis in the age of new therapies for familial hypercholesterolaemia (2021) (1)
- 4.P.277 Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in normolipidaemic subjects (1997) (1)
- Determinants of variable response to statin treatment in patients with familal hypercholesterolaemia. (2001) (1)
- LDL Apheresis — State of the Art (1992) (1)
- Treatment of hyperlipidaemia (1993) (1)
- Hyperthyroidism presenting as acute shoulder pain. (1973) (1)
- Role of plant sterols in lipid lowering--a safety issue. (2011) (1)
- Combination therapy with statins (2003) (1)
- The Role of Hmg-CoA Reductase Inhibitors in Homozygous Familial Hypercholesterolemia (1996) (1)
- Lipid-lowering therapy and its effect on atherosclerosis. (1989) (1)
- Turnover of apoB in low density lipoprotein sub-fractions. (1984) (1)
- Abstract: 101 PROPOSED EFFICACY CRITERIA AND CHOLESTEROL TARGETS FOR LDL APHERESIS (2009) (1)
- Mobilisation of tissue cholesterol by apheresis. (1990) (1)
- Plasma Exchange in Hyperlipidemia (1981) (1)
- Clinical consequences of hyperlipidaemia (1988) (1)
- Clinical pharmacology: New hopes for the treatment of coronary heart disease (1986) (1)
- Lipoprotein apheresis for refractory hyperlipidaemia : clinical indications and service requirements (2012) (1)
- 9 – The hyperlipidaemias (1985) (1)
- Statins and coronary heart disease (1996) (1)
- Receptor-mediated low-density lipoprotein catabolism (1982) (1)
- American Journal of Cardiology: Introduction (2005) (1)
- Of cholesterol-fed rabbits and LDL receptor-deficient men (2014) (1)
- Letters to the EditorPREVENTION OF CORONARY HEART DISEASE (1974) (0)
- Cholesterol-lowering drugs in familial defective apolipoprotein B-100 (1992) (0)
- THE EDITOR SPEAKS (1968) (0)
- Letter: Diet and coronary heart disease. (1974) (0)
- Management ofhyperlipidaemia: guidelines oftheBritish Hyperlipidaemia Association (1993) (0)
- Combined use of Plasma Exchange and Whole-Body Counting to Study Non-Steady-State Turnover of 131I-Low Density Lipoprotein (1976) (0)
- female . associated with sex-change in a coronary artery disease Hyperlipidaemia and premature (2008) (0)
- Efficacy and Mechanism of Action of Atorvastatin Compared with Simvastatin in Refractory Familial Hypercholesterolaemia (1997) (0)
- Dyslipidaemia and the military patient (2015) (0)
- LIPID-LOWERING DRUGS (1988) (0)
- The vaginal approach for diagnosis and treatment of ectopic pregnancy. (1957) (0)
- Hyperlipidemia and the progression of disease in the coronary circulation (1990) (0)
- Apolipoprotein E2, isoforms of different mobility: A novel cause of type III hyperlipoproteinaemia (1991) (0)
- Radical Therapy of Hypercholesterolaemia and Atherosclerosis (1983) (0)
- Aortic stenosis inhomozygous familial hypercholesterolaemia (1996) (0)
- The Lipid Hypothesis (2009) (0)
- 4MP06 Use of plasma markers as indices of sterol metabolism (2003) (0)
- Upregulation of Cholesterol Synthesis by Ldl Apheresis: Contrasting Effects in Familial Hypercholesterolaemia and Familial Combined Hyperlipidaemia (1995) (0)
- Cholesterol Substrate Availability as a Regulator of the Hepatic Secretion Rate of Very-Low-Density Lipoprotein Apolipoprotein B-100 (1995) (0)
- Coronary disease MANAGEMENT OF DYSLIPIDAEMIA (2004) (0)
- Lp(a) Apheresis, Endothelial Dysfunction and Potential for Extracorporeal Correction(Workshop1-12) (1997) (0)
- Book Review: Calcitonin (1969) (0)
- Nutritional osteomalacia and vitamin-D resistance. (1971) (0)
- Cholesterol synthesis is increased in NIDDM and decreases less than in controls during acutely induced hyperinsulinaemia (1995) (0)
- RANDOMIZED TRIAL OF LDL APHERESIS TO TREAT CORONARY ARTERY DISEASE IN FAMILIAL HYPERCHOLESTEROLAEMIA (1992) (0)
- Metabolic Consequences of Phospholipid Exchange between Intravenously Administered Egg Lecithin and Plasma Lipoproteins (1975) (0)
- Therapeutic response of vascular lesions is better in familial hypercholesterolaemia (fh) than in non-fh subjects (2014) (0)
- Effect of lipoprotein(a) apheresis on endotheliumdependent vasodilation in subjects with raised lipoprotein(a) levels (1995) (0)
- A symposium : cerivastatin : clinical efficacy and safety in the management of hyperlipidemia (1998) (0)
- Cardiac catheterization in homozygous familial hypercholesterolemia (1987) (0)
- Poster abstractDirect correlation between in vivo cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects (1994) (0)
- Aortic valve involvement in familial heterozygous hypercholesterolaemia: An echocardiographic study (1999) (0)
- AKIRA ENDO: THE DISCOVERY OF STATINS (2014) (0)
- Is thrombolytic therapy most effective when endogenous fibrinolysis is deficient (1996) (0)
- Effects of vasoactive stimuli on coronary vascular resistance in isolated perfused rabbit hearts: No vasospastic response to ergonovine with or without atherogenic diet (1983) (0)
- Serum cytokines and cardiovascular risk factors (1998) (0)
- Pathophysiology of plasma lipids (2006) (0)
- Effects ofshort termbetaadrenoreceptor blockade on serumlipids andlipoproteins inpatients with hypertension orcoronaryarterydisease (2017) (0)
- Obituary of Dr N.B. Myant. (2015) (0)
- Hypercholesterolemia with low versus high likelihood of polygenic origin: a single centre experience (2018) (0)
- Screening for dyslipidaemia (2006) (0)
- Factors determining inter-individual variability of response to statin therapy (2000) (0)
- UK consensus position on the management of homozygous familial hypercholesterolaemia and the introduction of new agents (2014) (0)
- Regional enteritis presenting as acute arthritis. (1968) (0)
- Phenobarbitone and Ethanol; Effects on Serum and Liver Lipids in the Rat (1975) (0)
- Book Review: Calcitonin 1969 (1970) (0)
- SHOR T COMMLNICA TION Normal adrenocortical response to adrenocorticotrophic hormone in patients with homozygous familial hy percholesterolaemia (1983) (0)
- Response to cholesterol-lowering therapy in patients with familial defective apolipoprotein B-100 (1991) (0)
- Dietary and lifestyle factors in dyslipidaemia (2006) (0)
- Corrigendum to "Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017" [Atherosclerosis 290 (November 2019) 44-51]. (2020) (0)
- Hyperosmolar glucose solution or prostaglandin-F2α for ectopic pregnancy (1990) (0)
- 750-4 The Influence of Lipoprotein(a) Levels on the Angiograpic Course of Coronary Atherosclerosis in Patients with High and Low LDL-C (1995) (0)
- Sharing experience: first patient in the UK to receive lomitapide therapy (2017) (0)
- What should be the goal of LDL-cholesterol lowering in coronary patients; a fixed level or a percent reduction? (1996) (0)
- and Plaque Morphology with Plasma Lipids and Coronary Heart Disease The Extracranial Carotid Artery in Familial Hypercholesterolemia: Relationship of Intimal-Medial Thickness (2014) (0)
- High prevalence off hypertriglyceridaemia and apoprotein abnormalities in coronary artery disease (1988) (0)
- Lipid-lowering drugs: focus on HMG-CoA reductase inhibitors. Introduction. (1991) (0)
- Dyslipidaemia as a risk factor for cardiovascular disease (2006) (0)
- Three years experience of lomitapide therapy in the uk (2019) (0)
- 3P-0737 Bile acid metabolism in hypertriglyceridemic patients. Effects of body mass index and triglyceride-lowering therapy by bezafibrate and fish-oil (2003) (0)
- New developments in pharmacotherapy : editorial (2004) (0)
- Management issues in primary care (2006) (0)
- Hyperosmolar glucose solution or prostaglandin-F2 alpha for ectopic pregnancy. (1990) (0)
- Normal and Pathological Lipoprotein Metabolism (2012) (0)
- The effect of different mutations in the LDL receptor on plasma lipid concentrations and the age of onset of coronary artery disease in patients with familial hypercholestrolaemia (FH) (1995) (0)
- Effects of Polyunsaturated Phospholipid on Cholesterol Efflux in Vitro and in Experimental Animals and Human Subjects (1987) (0)
- Lipid related consequencesofintestinal malabsorption (1989) (0)
- Clinical assessment of dyslipidaemia (2006) (0)
- 4.P.276 Visceral obesity is associated with hepatic oversecretion of very-low-density lipoprotein apolipoprotein B-100 (1997) (0)
- Combination therapy with ldl-apheresis & mevinolin for heterozygous familial hypercholesterolaemia (FH) (1987) (0)
- Rubella arthritis. (1966) (0)
- Pilot study of LDL apheresis in dyslipidaemic cardiac transplant recipients with accelerated coronary artery disease (1993) (0)
- Expert Opinion on Investigational Drugs (1998) (0)
- Effects of Hypercholesterolaemia on Coronary Vascular Resistance and Ventricular Contractility in Isolated Rabbit Hearts (1981) (0)
- Factors Influencing Receptor-Mediated Low Density Lipoprotein Catabolism (1983) (0)
- ANKYLOSING SPONDYLITIS, HYPERURICEMIA, AND ANOMALIES OF THE LUMBOSACRAL JUNCTION. A FAMILY STUDY. (1963) (0)
- EFFECTS OF PARTIAL GASTRECTOMY (1966) (0)
- Unpremeditated tribute to Akira Endo (2004) (0)
- Human C-Reactive Protein Binds Circulating Very Low Density Lipoproteins (1984) (0)
- LDL Subfractions and Atherosclerosis (1989) (0)
- Defects ofreceptor-mediated lowdensity lipoprotein catabolism inhomozygous familial hypercholesterolemia andhypothyroidism invivo (1981) (0)
- Abnormal Low-Density Lipoprotein Composition in Familial Hyper-Cholesterolaemia (1977) (0)
- Pharmacological management of dyslipidaemia (2006) (0)
- ROLE OF VITAMIN D IN POST-GASTRECTOMY BONE DISEASES. (1964) (0)
- Changes in plasma mevalonate predict responsiveness to HMG CoA reductase inhibitors (1993) (0)
- Predicting coronary heart disease. (1994) (0)
- Contrasting Effects on Plasma Lipoproteins of Intravenous Versus Oral Administration of a Triglyceride‐Phospholipid Emulsion (1975) (0)
- Use of plasma mevalonate to monitor HMG CoA reductase inhibition (1989) (0)
- hypercholesterolaemia . stenosis in familial the aortic root and coronary ostial echocardiographic assessment of Cross sectional and (2003) (0)
- Concurrently increased cholesterol synthesis and decreased cholesterol absorption in hypertriglyceridemia. Effects of bezafibrate therapy (2001) (0)
- Dietary reduction of serum cholesterol concentration (1991) (0)
- Guidelines on management of hyperlipidaemia (1991) (0)
- THE ROLE OF LDL APHERESIS IN THE TREATMENT OF FAMILIAL HYPERCHOLESTEROLAEMIA (1996) (0)
- A controlled study of niacinamide therapy. (1970) (0)
- coronary artery disease . apolipoprotein abnormalities in hypertriglyceridaemia and High prevalence of (2005) (0)
- Use of intravenous vitamin D3 in the detection of vitamin D deficiency. (1968) (0)
- HMG CoA reductase inhibitors and diet in familial hypercholesterolaemia. (1993) (0)
- coronary artery disease . patients with hypertension or serum lipids and lipoproteins in adrenoreceptor blockade on Effects of short term beta (0)
- THE DISCOVERY OF THE LDL RECEPTOR AND ITS ROLE IN CHOLESTEROL METABOLISM (2011) (0)
- A case of xanthomatous neuropathy (2006) (0)
- Lp(a): A comparison between patients with familial hyper-cholesterolaemia (FH) and a normal British population (1988) (0)
- High Frequency of Lipid and Apoprotein Abnormalities in Coronary Artery Disease (1987) (0)
- Coronary Calcium Score In Patients With Clinical Criteria For Familial Hypercholesterolaemia (2019) (0)
- Lipoprotein(a) may have contrasting effects on different aspects of atherosclerotic coronary disease. (1995) (0)
- A novel mutation causing dominant type III hyperlipoproteinaemia: APOEI Hammersmith (1995) (0)
- Pathology of Endocytosis with Special Reference to Lipoproteins (1981) (0)
- Significance of cholesterol absorption: inhibitory role of plant sterols and stanols. (2002) (0)
- Meeting Summary Atherosclerosis Regression, Arterial Wall Cell Interactions, and Atherogenic Lipoproteins (2005) (0)
- Hyperapobetalipoproteinaemia: an emerging risk factor for atherosclerosis. (1986) (0)
- An Appraisal of Methods for Calculating the Fractional Catabolic Rate of Low Density Lipoprotein in Turnover Studies in Humans (1975) (0)
- Use of plasma markers as indices of sterol metabolism (2004) (0)
- Altered fatty acid pattern in plasma lipoproteins of patients with intestinal malabsorption. (1971) (0)
- Biochemistry of metabolic pathways for exogenous and endogenous lipids (1988) (0)
This paper list is powered by the following services:
Other Resources About Gilbert Thompson
What Schools Are Affiliated With Gilbert Thompson ?
Gilbert Thompson is affiliated with the following schools:
